Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Review
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,887 | Dovepress* | 9,688+ | 1,512 | 11,200 | |
| PubMed Central* | 1,199 | 427 | 1,626 | ||
| Totals | 10,887 | 1,939 | 12,826 | ||
| *Since 7 September 2018 | |||||
View citations on PubMed Central and Google Scholar